Modifiable Risk Factors and Residual Risk Following Coronary RevascularizationTrevor Simard, Benjamin Hibbert, Pouya Motazedian et al.|Mayo Clinic Proceedings Innovations Quality & Outcomes|2021Cited by 14
Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary interventionRichard G. Jung, Benjamin Hibbert, Trevor Simard et al.|Thrombosis Research|2020Cited by 10
Physician prediction of 1-year mortality in the cardiac catheterization laboratory: comparison to a validated risk scoreKiran Sarathy, Benjamin Hibbert, Richard G. Jung et al.|Coronary Artery Disease|2020Cited by 3